Speakers

Speakers listed by session

NameCompany / AffiliationJob Title
Rafael BlascoINIA CSICPhDRole of Beta-2-Microglobulin in Vaccinia virus Internalization
Simon Corroyer-DulmontCentre for Structural Systems Biology, Leibniz Institute of VirologyPhD studentTHE PALISADE LAYER OF THE POXVIRUS CORE IS COMPOSED OF FLEXIBLE A10-TRIMERS
Chi-Kei KaoAcademia SinicaPostdoctoral fellowStructural and functional studies of H2 protein in the poxviral entry fusion complex
Der-Lii TzouInstitute of Chemistry/Academia SinicaResearch fellowStructural determination of vaccinia virus fusion protein A28 and its interaction with H2
Chuan KuAcademia SinicaAssociate Research FellowWidespread distribution and evolution of poxviral entry-fusion complex proteins in giant viruses
NameCompany / AffiliationJob Title
Wim BurmeisterInstitut de Biologie StructuraleProfessorStructure and flexibility of the DNA polymerase holoenzyme of vaccinia virus
Ilaria Dalla RosaThe Crick InstituteSenior scientistTopoisomerase 2 alpha, but not 2 beta promotes Vaccinia DNA replication
Rob InghamUniversity of AlbertaAssociate ProfessorElucidating poxvirus interactions with the host cell ubiquitin-proteasome system
Tim Newsome NewsomeUniversity of SydneyAssociate ProfessorLarge-scale single cell analysis of vaccinia virus infection and replication
Zhilong YangTexas A & M UniversityPrincipal InvestigatorVaccinia virus decapping enzyme D10 and mitochondria: A surprise marriage!
NameCompany / AffiliationJob Title
Ali Alejo-HerbergCISADrAfrican swine fever virus transmembrane protein pEP84R guides core assembly
Miguel Hernandez GonzalezThe Francis Crick InstitutePostdoctoral fellowA succession of two viral lattices drives vaccinia virus assembly
Yakin JaletaAlbert Einstein College of MedicineMD/PhD StudentUnveiling the Molecular Mechanisms of Orthopoxvirus Enveloped Virion Morphogenesis and Dissemination by Generating Deep Mutagenesis of vaccinia virus proteins A33 and A34
Michael WayThe Crick InstitutePrincipal InvestigatorKinesin-1 drives motility of intracellular mature virions during Vaccinia infection and in vitro
NameCompany / AffiliationJob Title
Isabel García-DorivalINIA-CSICFellowElucidation of the Cellular Interactome of African Swine Fever Virus Fusion Proteins and Identification of Potential Therapeutic Targets
Paul GershonUC IrvineProfessorVaccinia major structural protein P4a: Pathway of processing, conformational rearrangement and and higher order assembly inferred by chemical crosslinking-guided protein structure prediction
Crystal Gigante GiganteCDCMicrobiologistMultiple lineages of monkeypox virus detected in the United States, 2021- 2022
Natalia Khalatyan KhalatyanNorthwestern UniversityGraduate StudentSpecialized ribosomes during poxvirus infection
Preetam ParijaUniversity of SurreyPh.D. studentA role for the E3 ligase FBXO22 in antiviral immunity and its antagonism by orthopoxviruses
Martin PottsUniversity of CambridgePhD StudentComprehensive quantitative temporal proteomic, transcriptomic and interactome analysis of mpox
NameCompany / AffiliationJob Title
Dustin HancksUT Southwestern Medical CenterAssistant ProfessorPotent restriction of vaccinia virus by conserved ISG subprograms invoked by macronutrients
Megan McCaughanArizona State UniversityGraduate StudentUnveiling the Role of Z-RNA in Induction of Necroptosis: Macro-molecular Interactions During Virus and Oxidative Stress
Nathan MeadeNorthwestern UniversityPost-doctoral ResearcherThe F17 protein counteracts host responses to late stages of poxvirus replication
Anak Agung Dewi Megawati MegawatiUniversity of California, DavisPostdocTanapox virus and Yaba monkey tumor virus K3 orthologs show distinctive inhibition patterns of protein kinase R (PKR) from various primates
Daniel Pérez-NúñezCentro Biología Molecular Severo Ochoa (CBSO-CSIC)DrIdentification of new African swine fever virus genes involved in IFN-I control as potential new virulence factors.
Yan XiangUniversity of Texas Health San AntonioProfessorHuman SAMD9 is a Poxvirus-Activatable Anticodon Nuclease Inhibiting Codon-Specific Protein Synthesis
NameCompany / AffiliationJob Title
Don GammonUniversity of Texas Southwestern Medical CenterPrincipal InvestigatorPoxvirus A51R Proteins Antagonize Microtubule Dynamics, Intracellular Transport, and Cell-Intrinsic Restrictions in Macrophages Using a Tau-Like Motif
Alexandria KruegerUniversity of Nebraska - LincolnPostdoctoral ScholarThe poxviral B12 pseudokinase targets the cellular VRK1 kinase and dysregulates interferon-induced gene expression through subversion of host BAF and cGAS responses to DNA
Jia Liu LiuUniversity of Arkansas for Medical SciencesAssociate Professor, Department of Microbiology & ImmunologyMyxoma virus M062R-null mutant induced a unique pro-inflammatory state in human monocyte/macrophages
Sha TaoHHUDr.Autophagy in myeloid cells is essential to generate protective CD8+ T cell memory in viral infection
Zhilong YangTexas A& M UnivesityPIVaccinia virus growth factor-mediated signaling pathway stimulates ATP citrate lyase phosphorylation and enhances neutral lipid biosynthesis
Junda ZhuChina Agricultural UniversityPostdoctoral FellowHuman FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1
NameCompany / AffiliationJob Title
Ralf AmannUniversity Hospital TuebingenPrincipal InvestigatorAn Orf Virus-based Vaccine Platform Overcomes Anti-Vector Immunity, Facilitating Effective Booster Vaccinations and Enhancing Cellular and Humoral Immunity
Giuseppe AndreacchioHeinrich-Heine-University of DüsseldorfPhD studentA novel MVA-based vaccine against Chlamydia trachomatis elicits potent T cell response in HLA transgenic mice.
Alec FreynModernaSenior ScientistDevelopment of a quadrivalent mRNA-lipid nanoparticle vaccine to elicit cross-reactive immune responses against diverse Orthopoxviruses
Juan Garcia Arriaza García-ArriazaCentro Nacional de BiotecnologíaResearch scientist. PhD.MVA-based vaccine candidates against COVID-19 expressing SARS-CoV-2 S protein trigger robust immunogenicity and complete efficacy against SARS-CoV-2 infection in various animal models
Ingo JordanProBioGen AGVP Vaccine StrategiesInsertion of an innate immunity factor into the inverted terminal repeats for rapid selection of double-copy recombinant MVA-CR19
Prof. Dr. Asisa VolzInstitute of Virology, University of Veterinary Medicine HannoverProf. Dr.Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
NameCompany / AffiliationJob Title
Alasdair HoodUniversity of SurreyPhD StudentSelf-adjuvanting MVA encoding a functional copy of cGAS enhances activation of innate immunity
Bertram JacobsArizona State UniversityPrincipal InvestigatorReplication-competent NYVAC-KC vector expressing modified spike protein and administered by intranasal route or by scarification protects against mouse-adapted SARS-CoV-2 in mice
Amy MacNeillColorado State UniversityPrincipal InvestigatorBlocking interferon-α promotes myxoma virus replication in canine cells, but JAK1 inhibition does not improve outcome in myxoma virus treated dogs with sarcoma
Luis Sigal SigalThomas Jefferson University, Department of Microbiology and ImmunologyProfessor and Vice-Chair for ResearchCD8 T-cell mRNA-LNP vaccines do not require CD4 T-cell help to protect from poxvirus disease
Nathalie SilvestreTransgeneHead of Vectorology laboratoryTG4050, a personalized neoantigen MVA vaccine in head and neck and ovarian cancer
NameCompany / AffiliationJob Title
Stephen CarroUniversity of PennsylvaniaGraduate StudentEctromelia C15: a potent orthopox virulence factor that targets both innate and adaptive immunity
Don GammonUniversity of Texas Southwestern Medical CenterAssistant ProfessorPoxvirus A51R Proteins Counter a Novel FACT-ETS-1 Antiviral Response (FEAR) Pathway
Guna Karupiah KarupiahUniversity of TasmaniaAssociate ProfessorReplication-competent, but not replication-poor, orthopoxvirus infection induces robust neutralising antibody responses due to high rates of somatic hypermutations and antibody affinity maturation
Jia LiuUniversity of Arkansas for Medical SciencesAssociate Professor, Department of Microbiology & ImmunologyHost SAMD9 protein promotes PKR dependent eIF2alpha phosphorylation that is inhibited by myxoma virus infection.
Daniel Pérez-NúñezCentro Biología Molecular Severo Ochoa (CBSO-CSIC)DrMolecular determinants of African swine fever virus hemadsorption and virulence
Luis SigalThomas Jefferson University, Department of Microbiology and ImmunologyProfessor and Vice-Chair for ResearchThe NF-κB binding site in the Ifnb1 gene promoter is indispensable for resistance to ectromelia virus infection
NameCompany / AffiliationJob Title
Isabel Alonso SánchezCentro de Biología Molecular Severo Ochoa (CBMSO) - CSICPhD StudentTNF inhibitory activity of the TNF receptor CrmB from mpox virus isolates
Carlos Maluquer de MotesUniversity of SurreyDrSTING Agonism Abrogates Monkeypox Virus Replication
Jacqueline WilliamsArizona State UniversityPost-docMonkeypox/Mpox Virus: The Battle Between Necroptosis Inhibition and the Antiviral Innate Response.
Nhien WynnCenters for Disease ControlMicrobiologistPhenotypic testing for tecovirimat resistance during the 2022 mpox outbreak
P.S. SatheshkumarCDCMicrobiologistInhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry
Audrey MathenyCenters for Disease Control and PreventionMicrobiologistIn vitro and in vivo evaluation of monoclonal antibodies against orthopoxviruses
Francisco Javier Álvarez-de MirandaCentro Biología Molecular Severo Ochoa (CBMSO) - CSICPhD StudentDevelopment of poxvirus-inspired soluble IFN-I decoy receptors
NameCompany / AffiliationJob Title
Laura AshtonColorado State UniversityResearch AssociateLocalization of Walleye Dermal Sarcoma Virus OrfC in tumor cells lines infected with myxoma virus expressing OrfC
Shanza Baseer TariqMemorial Sloan Kettering Cancer CenterResearch TechnicianElucidating the role of type I IFN in recombinant oncolytic vaccinia-induced antitumor immunity
Liang DengMemorial Sloan Kettering Cancer CenterAssociate Member/Associate AttendingIL-12-expressing highly immunogenic recombinant modified vaccinia virus Ankara reprograms tumor-infiltrating myeloid cells to overcome immune resistance
Ryan NoyceUniversity of AlbertaAssistant ProfessorExploring novel virus-host interactions to emerging poxviruses and the development of next-generation virus-vectored vaccines
NameCompany / AffiliationJob Title
Pip BeardKeele UniversityProfessorDefining the role of insect vectors Aedes aegypti, Stomoxys calcitrans, and Culicoides nubeculosus in the transmission of lumpy skin disease
Laure Bosquillon de JarcyCharité Universitätsmedizin BerlinPostdoctoral FellowMPOX Virus Infects Human PBMCs in a Type I Interferon-Sensitive Manner
Cécile HERATECEA IDMITResearcherInvestigation of Monkeypox virus infection and sexual transmission in Cynomolgus macaque
Stefan RothenburgUC DavisAssociate ProfessorDiverse inhibition profiles of protein kinase R antagonists from various cowpox viruses
Lisa-Marie SchünemannUniversity of Veterinary Medicine Hannover, FoundationDr.Development of a preclinical model for human mpox disease using skin scarification in CAST/Eij
NameCompany / AffiliationJob Title
Jeff DotyCDCBiologstZoonotic sources of Alaskapox virus
Christina HutsonCDCChief Poxvirus and Rabies Branch/ PhDAn Overview of Smallpox Tools Utilized For Mpox and CDC Laboratory Efforts During the Outbreak
Jason KindrachukUniversity of ManitobaAssociate Professor; Canada Research ChairA prospective and retrospective multi-center, cohort study for surveillance, clinical characterization and determination of relative vaccine effectiveness for mpox virus by IMReC
Todd Smith SmithCDCMicrobiologistValidation of a novel, lethal, small-animal model of smallpox
Chathura SuraweeraAustralian National UniversityPost doctoral FellowMonkeypox virus C7L is a Bcl-2-fold protein that binds human pro-apoptotic Bcl-2 proteins